DOSSIER · 13F Holders · Q1 2026
CNSP
CNS Pharmaceuticals Inc
11 institutions still hold CNS Pharmaceuticals Inc as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 18978H508·11 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
11 institutions reported CNSP in Q1 2026. Stonepine Capital Management, LLC leads at 41.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.